Image pharmaphorum Editor News GSK strengthens core prescription business with Sin hire In a drive to boost its search for innovative products worldwide, GlaxoSmithKline (GSK) has hired Kevin Sin from Roche. News Pharma playing catch-up as GDPR deadline nears Pharma will need to change its culture White Papers Sponsored Thinking niche: the challenge of pharma's focus on small pat... With the pharma industry putting the ‘blockbuster’ age behind it and moving into meeting needs across myriad niche disease areas, what is the impact and therefore change of requirement in terms of News FDA rejects Pfizer Herceptin biosimilar, wants technical inf... A Pfizer-produced biosimilar of Roche’s blockbuster breast cancer drug, Herceptin, has been rejected by US regulators. Load more results
News GSK strengthens core prescription business with Sin hire In a drive to boost its search for innovative products worldwide, GlaxoSmithKline (GSK) has hired Kevin Sin from Roche.
White Papers Sponsored Thinking niche: the challenge of pharma's focus on small pat... With the pharma industry putting the ‘blockbuster’ age behind it and moving into meeting needs across myriad niche disease areas, what is the impact and therefore change of requirement in terms of
News FDA rejects Pfizer Herceptin biosimilar, wants technical inf... A Pfizer-produced biosimilar of Roche’s blockbuster breast cancer drug, Herceptin, has been rejected by US regulators.
News Novo Nordisk beefs up in oral obesity drugs with Vivtex deal Novo Nordisk is leaving no stone unturned in its bid to maintain its position in weight-loss therapies as it signs a $2.1bn alliance with Vivtex.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
